Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Repaglinide is a rapid-acting oral hypoglycemic agent used to treat type 2 diabetes. Produced via chemical synthesis, its molecular formula is C22H28N2O4 with CAS No. 139362-57-5.
Application
- Pharmaceutical Manufacturing: Active Pharmaceutical Ingredient (API) for tablet formulation.
- Metabolic Therapy: Postprandial glucose control in combination with lifestyle modifications.
- Research & Development: Clinical trials for new antidiabetic protocols.
Precautions
Contraindicated in type 1 diabetes and diabetic ketoacidosis. Store in a cool, dry place away from light. Handle with PPE to avoid inhalation or skin contact during processing.